Quarterly report pursuant to Section 13 or 15(d)

Note 11 - Segment and Geographic Data - Summary by Reporting and Operating Segments (Details)

v3.21.2
Note 11 - Segment and Geographic Data - Summary by Reporting and Operating Segments (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Product sales, net $ 2,425,738 $ 167,674 $ 5,350,445 $ 1,979,060  
Operating Income (Loss) (2,872,572) (3,172,890) (3,856,945) (4,781,496)  
Depreciation and Amortization 14,834 21,138 35,760 54,457  
Income (loss) before taxes and equity in earnings of affiliates (2,600,853) (3,176,952) (3,587,761) (4,789,655)  
Total assets 21,059,666   21,059,666   $ 19,571,450
Corporate, Non-Segment [Member]          
Operating Income (Loss) (2,262,369) (1,708,225) (3,477,056) (3,073,399)  
Depreciation and Amortization 12,809 17,416 28,178 45,224  
Income (loss) before taxes and equity in earnings of affiliates (2,062,748) (1,710,177) (3,277,785) (3,077,500)  
Total assets 13,223,587   13,223,587   12,612,147
Dental Segment [Member]          
Product sales, net 2,404,738 165,674 5,258,395 1,969,260  
Dental Segment [Member] | Operating Segments [Member]          
Product sales, net 2,404,738 165,674 5,258,395 1,969,260  
Operating Income (Loss) 524,798 (650,236) 1,650,831 (223,856)  
Depreciation and Amortization 860 3,101 2,566 8,800  
Income (loss) before taxes and equity in earnings of affiliates 598,166 (651,384) 1,723,284 (225,845)  
Total assets 6,639,102   6,639,102   6,035,645
Medical Segment [Member]          
Product sales, net 21,000 2,000 92,050 9,800  
Medical Segment [Member] | Operating Segments [Member]          
Product sales, net 21,000 2,000 92,050 9,800  
Operating Income (Loss) (1,135,001) (814,429) (2,030,720) (1,484,241)  
Depreciation and Amortization 1,165 621 5,016 4,333  
Income (loss) before taxes and equity in earnings of affiliates (1,136,271) $ (815,391) (2,033,260) $ (1,486,310)  
Total assets $ 1,196,977   $ 1,196,977   $ 923,658